COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease
Authors
Keywords
-
Journal
Translational Research
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2020-12-20
DOI
10.1016/j.trsl.2020.12.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human genetics of life-threatening influenza pneumonitis
- (2020) Qian Zhang HUMAN GENETICS
- The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections
- (2020) Eri Katsuyama et al. Cell Reports
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19
- (2020) Alfred H.J. Kim et al. ANNALS OF INTERNAL MEDICINE
- Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know
- (2020) Jinoos Yazdany et al. ANNALS OF INTERNAL MEDICINE
- COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine
- (2020) Emanuele Bozzalla Cassione et al. ANNALS OF THE RHEUMATIC DISEASES
- Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19
- (2020) Maximilian F Konig et al. ANNALS OF THE RHEUMATIC DISEASES
- Are patients with systemic lupus erythematosus at increased risk for COVID-19?
- (2020) Ennio Giulio Favalli et al. ANNALS OF THE RHEUMATIC DISEASES
- Hydroxychloroquine shortages during the COVID-19 pandemic
- (2020) Arielle Mendel et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’
- (2020) Kristin M D’Silva et al. ANNALS OF THE RHEUMATIC DISEASES
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2020) Milena Gianfrancesco et al. ANNALS OF THE RHEUMATIC DISEASES
- Patients with lupus with COVID-19: University of Michigan experience
- (2020) Beth Wallace et al. ANNALS OF THE RHEUMATIC DISEASES
- SARS-CoV-2 infection among patients with systemic autoimmune diseases
- (2020) Giacomo Emmi et al. AUTOIMMUNITY REVIEWS
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
- (2020) Carly G.K. Ziegler et al. CELL
- Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
- (2020) Zhuo Zhou et al. Cell Host & Microbe
- Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review
- (2020) Chaturaka Rodrigo et al. CLINICAL MICROBIOLOGY AND INFECTION
- The mechanistic target of rapamycin (mTOR): Novel Considerations as an Antiviral Treatment and Possibilities for COVID-19
- (2020) Kenneth Maiese CURRENT NEUROVASCULAR RESEARCH
- Systemic lupus erythematosus and risk of infection
- (2020) Megan R.W. Barber et al. Expert Review of Clinical Immunology
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy
- (2020) Graziano Onder et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
- (2020) Giacomo Grasselli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Type I IFN immunoprofiling in COVID-19 patients
- (2020) Sophie Trouillet-Assant et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Angiotensin‐converting enzyme‐2 ( ACE2 ), SARS‐CoV ‐2 and pathophysiology of coronavirus disease 2019 ( COVID ‐19)
- (2020) Arno R. Bourgonje et al. JOURNAL OF PATHOLOGY
- Severe pneumonia in Chinese patients with systemic lupus erythematosus
- (2020) Lingli Peng et al. LUPUS
- The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic
- (2020) Philip C. Robinson et al. Nature Reviews Rheumatology
- Hospitalization and Mortality among Black Patients and White Patients with Covid-19
- (2020) Eboni G. Price-Haywood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
- (2020) Louise Bowles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
- (2020) Rebecca Haberman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Study on the public psychological states and its related factors during the outbreak of coronavirus disease 2019 (COVID-19) in some regions of China
- (2020) Yenan Wang et al. Psychology Health & Medicine
- Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases
- (2020) Cynthia Magro et al. Translational Research
- Widening Disparities Among Patients with Rheumatic Diseases in the COVID‐19 Era: An Urgent Call to Action
- (2020) Candace H. Feldman et al. Arthritis & Rheumatology
- An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?
- (2020) Giuseppe Terrazzano et al. Frontiers in Pharmacology
- COVID-19 and the impact of social determinants of health
- (2020) Elissa M Abrams et al. Lancet Respiratory Medicine
- Interferon-α2b Treatment for COVID-19
- (2020) Qiong Zhou et al. Frontiers in Immunology
- Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Bo Diao et al. Frontiers in Immunology
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Gender Differences in Patients With COVID-19: Focus on Severity and Mortality
- (2020) Jian-Min Jin et al. Frontiers in Public Health
- Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
- (2020) Caleb P. Skipper et al. ANNALS OF INTERNAL MEDICINE
- Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments
- (2020) Zoé Gendebien et al. ANNALS OF THE RHEUMATIC DISEASES
- COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases
- (2020) Clementina López-Medina et al. ANNALS OF THE RHEUMATIC DISEASES
- Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey
- (2020) Marlene Plüß et al. ANNALS OF THE RHEUMATIC DISEASES
- Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases
- (2020) Jose L Pablos et al. ANNALS OF THE RHEUMATIC DISEASES
- Telemedicine will not keep us apart in COVID-19 pandemic
- (2020) Simone Perniola et al. ANNALS OF THE RHEUMATIC DISEASES
- Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak
- (2020) Jan Holubar et al. ANNALS OF THE RHEUMATIC DISEASES
- Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics
- (2020) Arielle Mendel et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective study
- (2020) Yao Huang et al. ANNALS OF THE RHEUMATIC DISEASES
- COVID-19 in patients with rheumatic diseases: what is the real mortality risk?
- (2020) Claudia Marques et al. ANNALS OF THE RHEUMATIC DISEASES
- Exacerbation of immune thrombocytopaenia triggered by COVID-19 in patients with systemic lupus erythematosus
- (2020) Yasushi Kondo et al. ANNALS OF THE RHEUMATIC DISEASES
- Hydroxychloroquin ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis
- (2020) Mendel E Singer et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of COVID-19 pandemic on hospitalisation of patients with systemic lupus erythematosus (SLE): report from a tertiary hospital during the peak of the pandemic
- (2020) Seow Lin Chuah et al. ANNALS OF THE RHEUMATIC DISEASES
- Neutrophil Extracellular Traps (NETs) Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome
- (2020) Elizabeth A Middleton et al. BLOOD
- Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients
- (2020) Nan Wang et al. Cell Host & Microbe
- Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
- (2020) Amr H. Sawalha et al. CLINICAL IMMUNOLOGY
- The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
- (2020) Sara Mastaglio et al. CLINICAL IMMUNOLOGY
- Determinants of COVID-19 disease severity in patients with underlying rheumatic disease
- (2020) C. Sieiro Santos et al. CLINICAL RHEUMATOLOGY
- Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology
- (2020) Eduardo Mantovani Cardoso et al. CLINICAL RHEUMATOLOGY
- Type I interferon antagonists in clinical development for lupus
- (2020) Jacqueline L. Paredes et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Genetic variability in the expression of the SARS-CoV-2 host cell entry factors across populations
- (2020) Lourdes Ortiz-Fernández et al. GENES AND IMMUNITY
- Endothelial Injury and Thrombotic Microangiopathy in COVID-19: Treatment with the Lectin-Pathway Inhibitor Narsoplimab
- (2020) Alessandro Rambaldi et al. IMMUNOBIOLOGY
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
- (2020) W. Joost Wiersinga et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Presence of Genetic Variants Among Young Men With Severe COVID-19
- (2020) Caspar I. van der Made et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients
- (2020) M. Zen et al. JOURNAL OF AUTOIMMUNITY
- Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers
- (2020) Peter Izmirly et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antiphospholipid antibodies in patients with COVID‐19: A relevant observation?
- (2020) Katrien M. J. Devreese et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine
- (2020) Bethany D Harris et al. LUPUS
- Severe refractory thrombocytopenia in a woman positive for coronavirus disease 2019 with lupus and antiphospholipid syndrome
- (2020) Alina Hayden et al. LUPUS
- Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis
- (2020) Julien Carvelli et al. NATURE
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- A single-cell atlas of the peripheral immune response in patients with severe COVID-19
- (2020) Aaron J. Wilk et al. NATURE MEDICINE
- Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection
- (2020) Vijendra Ramlall et al. NATURE MEDICINE
- Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications
- (2020) Joan T. Merrill et al. Nature Reviews Rheumatology
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obesity and COVID‐19: The mTOR pathway as a possible culprit
- (2020) Alireza Bolourian et al. Obesity Reviews
- Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes
- (2020) Fernando Montero et al. RHEUMATOLOGY INTERNATIONAL
- Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
- (2020) Divij Mathew et al. SCIENCE
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Acute respiratory viral adverse events during use of antirheumatic disease therapies: a scoping review
- (2020) Adam Kilian et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- COVID-19 in systemic lupus erythematosus: data from a survey on 417 patients
- (2020) Dr. Giuseppe A. Ramirez et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19
- (2020) Wei Luo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
- (2020) Sara De Biasi et al. Nature Communications
- Leveraging the United States Epicenter to Provide Insights on COVID‐19 in Patients with Systemic Lupus Erythematosus
- (2020) Ruth Fernandez‐Ruiz et al. Arthritis & Rheumatology
- COVID‐19 in Patients with Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and DMARDs on Clinical Outcomes
- (2020) Rebecca H. Haberman et al. Arthritis & Rheumatology
- Impact of COVID-19 on Acute Stroke Presentation at a Comprehensive Stroke Center
- (2020) Masaki Nagamine et al. Frontiers in Neurology
- The laboratory tests and host immunity of COVID-19 patients with different severity of illness
- (2020) Feng Wang et al. JCI Insight
- Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Morayma Reyes Gil et al. JAMA Network Open
- White Counties Stand Apart: The Primacy of Residential Segregation in COVID-19 and HIV Diagnoses
- (2020) Gregorio A. Millett et al. AIDS PATIENT CARE AND STDS
- COVID ‐19 and lymphangioleiomyomatosis: Experience at a reference center and the potential impact of the use of mTOR inhibitors
- (2020) Bruno Guedes Baldi et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Tuberous sclerosis complex (TSC), lymphangioleiomyomatosis, and COVID ‐19: The experience of a TSC clinic in Italy
- (2020) Angela Peron et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Systemic lupus erythematosus and COVID-19: what we know so far
- (2020) Giuseppe A. Ramirez et al. ANNALS OF THE RHEUMATIC DISEASES
- Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19
- (2020) Naoki Kaneko et al. CELL
- Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19
- (2020) Jeffrey Laurence et al. CLINICAL IMMUNOLOGY
- Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine
- (2020) Homam Ibrahim et al. CLINICAL IMMUNOLOGY
- Lupus anticoagulant in patients with COVID‐19
- (2020) Ariella Tvito et al. International Journal of Laboratory Hematology
- COVID‐19 infection in patients with systemic lupus erythematosus: Data from the Asia Pacific Lupus Collaboration
- (2020) Jiacai Cho et al. International Journal of Rheumatic Diseases
- Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19
- (2020) Pierre-François Dequin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19
- (2020) Bruno M. Tomazini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Excess Deaths From COVID-19 and Other Causes, March-July 2020
- (2020) Steven H. Woolf et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Case of Systemic Lupus Erythematosus Flare Triggered by Severe Coronavirus Disease 2019
- (2020) Sairam Raghavan et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis
- (2020) Panagiotis Skendros et al. JOURNAL OF CLINICAL INVESTIGATION
- Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19
- (2020) Coraline Radermecker et al. JOURNAL OF EXPERIMENTAL MEDICINE
- SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology
- (2020) Flavio Protasio Veras et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Biologics targeting type I interferons in SLE: A meta-analysis and systematic review of randomised controlled trials
- (2020) Jeffery Wei Heng Koh et al. LUPUS
- The risk of hospitalized infection in patients with systemic lupus erythematosus treated with hydroxychloroquine
- (2020) Ryoko Sakai et al. LUPUS
- Comparative efficacy and safety of mycophenolate mofetil and cyclophosphamide in the induction treatment of lupus nephritis
- (2020) Yue-Peng Jiang et al. MEDICINE
- Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor
- (2020) Olusegun O. Onabajo et al. NATURE GENETICS
- Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19
- (2020) Matthew C. Woodruff et al. NATURE IMMUNOLOGY
- Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
- (2020) Jan C. Holter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study
- (2020) Jose Luis Rodriguez-Garcia et al. RHEUMATOLOGY
- Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
- (2020) Prabhu S. Arunachalam et al. SCIENCE
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- SARS CoV-2 presenting as Lupus Erythematosus-Like Syndrome
- (2020) Sahar El Aoud et al. Disaster Medicine and Public Health Preparedness
- A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics
- (2020) Magnus Nakrem Lyngbakken et al. Nature Communications
- Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers
- (2020) Benjamin S. Abella et al. JAMA Internal Medicine
- COVID-19 Among American Indian and Alaska Native Persons — 23 States, January 31–July 3, 2020
- (2020) Sarah M. Hatcher et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Evaluation of Mental Health Factors among People with Systemic Lupus Erythematosus during the SARS-CoV-2 Pandemic
- (2020) Paweł Wańkowicz et al. Journal of Clinical Medicine
- SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2
- (2020) Jingfang Mu et al. Cell Discovery
- Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab
- (2020) Igor Kos et al. Frontiers in Oncology
- Racism, Not Race, Drives Inequity Across the COVID-19 Continuum
- (2020) Rohan Khazanchi et al. JAMA Network Open
- Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19
- (2020) Yapeng Su et al. CELL
- Type I interferon in the pathogenesis of systemic lupus erythematosus
- (2020) Mariana Postal et al. CURRENT OPINION IN IMMUNOLOGY
- Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission
- (2020) Hannah Peckham et al. Nature Communications
- Assessment of Racial/Ethnic Disparities in Hospitalization and Mortality in Patients With COVID-19 in New York City
- (2020) Gbenga Ogedegbe et al. JAMA Network Open
- Association of Race and Ethnicity With COVID‐19 Outcomes in Rheumatic Disease: Data From the COVID‐19 Global Rheumatology Alliance Physician Registry
- (2020) Milena A. Gianfrancesco et al. Arthritis & Rheumatology
- Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Phillip D Monk et al. Lancet Respiratory Medicine
- Plasmacytoid Dendritic Cells: Development, Regulation, and Function
- (2019) Boris Reizis IMMUNITY
- The Systemic Lupus Erythematosus Infection Predictive Index (LIPI): A Clinical-Immunological Tool to Predict Infections in Lupus Patients
- (2019) Jiram Torres-Ruiz et al. Frontiers in Immunology
- Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis
- (2019) Tianbiao Zhou et al. Drug Design Development and Therapy
- Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome
- (2019) Ramadan A. Ali et al. Nature Communications
- IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes
- (2019) Rudragouda Channappanavar et al. JOURNAL OF CLINICAL INVESTIGATION
- Management strategies and future directions for systemic lupus erythematosus in adults
- (2019) Laura Durcan et al. LANCET
- Factors Associated with Participation in Rheumatic Disease‐Related Research among Underrepresented Populations: A Qualitative Systematic Review
- (2019) Kaitlin Lima et al. ARTHRITIS CARE & RESEARCH
- Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation
- (2019) Anush Martirosyan et al. Frontiers in Immunology
- Infectious processes and systemic lupus erythematosus
- (2019) Rebeca Illescas‐Montes et al. IMMUNOLOGY
- Association between lymphocyte subsets and cytomegalovirus infection status among patients with systemic lupus erythematosus
- (2019) Ling Qin et al. MEDICINE
- Trial of Anifrolumab in Active Systemic Lupus Erythematosus
- (2019) Eric F. Morand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-Cytokine Autoantibodies in Systemic Lupus Erythematosus
- (2019) Hwee Siew Howe et al. Cells
- Role of Epstein-Barr virus infection in SLE: gene-environment interactions at the molecular level
- (2018) David S Pisetsky ANNALS OF THE RHEUMATIC DISEASES
- Glucocorticoids and antimalarials in systemic lupus erythematosus
- (2018) Amaia Ugarte et al. CURRENT OPINION IN RHEUMATOLOGY
- Lupus and vaccinations
- (2018) Alexis Mathian et al. CURRENT OPINION IN RHEUMATOLOGY
- Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis
- (2018) Camille Garnier et al. JOURNAL OF RHEUMATOLOGY
- Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial
- (2018) Zhi-Wei Lai et al. LANCET
- Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus
- (2018) S Iwata et al. LUPUS
- Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity
- (2018) John B. Harley et al. NATURE GENETICS
- Comparison of Remission and Lupus Low Disease Activity State in Damage Prevention in a United States Systemic Lupus Erythematosus Cohort
- (2018) Michelle Petri et al. Arthritis & Rheumatology
- Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus
- (2018) Takayuki Katsuyama et al. Frontiers in Immunology
- Mortality in systemic lupus erythematosus: causes, predictors and interventions
- (2018) Vanessa Ocampo-Piraquive et al. Expert Review of Clinical Immunology
- Severe infections in patients with lupus nephritis treated with immunosuppressants: A retrospective cohort study
- (2017) Cynthia C Lim et al. NEPHROLOGY
- Severe viral respiratory infections in children withIFIH1loss-of-function mutations
- (2017) Samira Asgari et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications
- (2017) Candace H. Feldman et al. Arthritis & Rheumatology
- The Incidence and Prevalence of Systemic Lupus Erythematosus in New York County (Manhattan), New York: The Manhattan Lupus Surveillance Program
- (2017) Peter M. Izmirly et al. Arthritis & Rheumatology
- In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis
- (2017) He Meng et al. Arthritis & Rheumatology
- Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
- (2017) Richard Furie et al. Arthritis & Rheumatology
- Infection in systemic lupus erythematosus, similarities, and differences with lupus flare
- (2017) Ju-Yang Jung et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis
- (2016) Jasvinder A. Singh et al. BMC Medicine
- Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
- (2016) Rudragouda Channappanavar et al. Cell Host & Microbe
- Role of Leptin and SOCS3 in Inhibiting the Type I Interferon Response During Obesity
- (2016) Elí Terán-Cabanillas et al. INFLAMMATION
- Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus: a systematic literature review
- (2016) C E Henegar et al. LUPUS
- Systematic review of case reports of antiphospholipid syndrome following infection
- (2016) N Abdel-Wahab et al. LUPUS
- High frequency of immunodeficiency-like states in systemic lupus erythematosus: a cross-sectional study in 300 consecutive patients
- (2016) Sandro F. Perazzio et al. RHEUMATOLOGY
- Mortality in Systemic Lupus Erythematosus: an Updated Review
- (2016) César E. Fors Nieves et al. Current Rheumatology Reports
- Infection and Lupus: Which Causes Which?
- (2016) Sarah Doaty et al. Current Rheumatology Reports
- Clearance Deficiency and Cell Death Pathways: A Model for the Pathogenesis of SLE
- (2016) Aparna Mahajan et al. Frontiers in Immunology
- Effects of annual influenza vaccination on morbidity and mortality in patients with Systemic Lupus Erythematosus: A Nationwide Cohort Study
- (2016) Chi-Ching Chang et al. Scientific Reports
- Influenza A (H1N1) virus infection triggers severe pulmonary inflammation in lupus-prone mice following viral clearance
- (2015) Samantha R. Slight-Webb et al. JOURNAL OF AUTOIMMUNITY
- Age-Associated Failure To Adjust Type I IFN Receptor Signaling Thresholds after T Cell Activation
- (2015) Guangjin Li et al. JOURNAL OF IMMUNOLOGY
- Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases
- (2015) Andras Perl Nature Reviews Rheumatology
- Effect of mycophenolate mofetil on the white blood cell count and the frequency of infection in systemic lupus erythematosus
- (2015) Ananta Subedi et al. RHEUMATOLOGY INTERNATIONAL
- Selective Loss of Signaling Lymphocytic Activation Molecule Family Member 4-Positive CD8+ T Cells Contributes to the Decreased Cytotoxic Cell Activity in Systemic Lupus Erythematosus
- (2015) Katalin Kis-Toth et al. Arthritis & Rheumatology
- Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
- (2014) Ian N Bruce et al. ANNALS OF THE RHEUMATIC DISEASES
- Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
- (2014) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Dysregulation of antiviral helicase pathways in systemic lupus erythematosus
- (2014) Luciana Oliveira et al. Frontiers in Genetics
- Lymphopaenia, Anti-Ro/Anti-RNP Autoantibodies, Renal Involvement and Cyclophosphamide Use Correlate with Increased Risk of Herpes Zoster in Patients with Systemic Lupus Erythematosus
- (2013) S Hu et al. ACTA DERMATO-VENEREOLOGICA
- Th22, but not Th17 Might be a Good Index to Predict the Tissue Involvement of Systemic Lupus Erythematosus
- (2013) Xu-yan Yang et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) – results from a nationwide cohort in Germany (GRAID)
- (2013) M Witt et al. LUPUS
- Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies
- (2013) A Danza et al. LUPUS
- N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial
- (2012) Zhi-Wei Lai et al. ARTHRITIS AND RHEUMATISM
- Lupus and Epstein-Barr
- (2012) Judith A. James et al. CURRENT OPINION IN RHEUMATOLOGY
- Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus
- (2011) Alyssa M. Morimoto et al. ARTHRITIS AND RHEUMATISM
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report
- (2011) Konstantinos Tselios et al. BMC INFECTIOUS DISEASES
- Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency
- (2011) Vanessa Sancho-Shimizu et al. JOURNAL OF CLINICAL INVESTIGATION
- Interferon Alpha as a Primary Pathogenic Factor in Human Lupus
- (2011) Timothy B. Niewold JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Systemic Lupus Erythematosus
- (2011) George C. Tsokos NEW ENGLAND JOURNAL OF MEDICINE
- Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus
- (2010) Corinna E. Weckerle et al. ARTHRITIS AND RHEUMATISM
- Hydroxychloroquine in SLE: old drug, new perspectives
- (2010) Thomas Dörner Nature Reviews Rheumatology
- Impaired interferon signaling is a common immune defect in human cancer
- (2009) R. J. Critchley-Thorne et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rare Variants of IFIH1, a Gene Implicated in Antiviral Responses, Protect Against Type 1 Diabetes
- (2009) S. Nejentsev et al. SCIENCE
- Predictors of major infections in systemic lupus erythematosus
- (2009) Guillermo Ruiz-Irastorza et al. ARTHRITIS RESEARCH & THERAPY
- Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
- (2008) G Ruiz-Irastorza et al. ANNALS OF THE RHEUMATIC DISEASES
- Infections as triggers and complications of systemic lupus erythematosus
- (2008) A Doria et al. AUTOIMMUNITY REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More